An all-Swiss consortium
Fleck: quantum computing for
the life sciences
Fleck is an eight-party all-Swiss consortium that will use quantum computing to address three key application domains: contrast agent discovery; drug design; and brain cancer detection using ultra-low field
(ULF) MR imaging.
The consortium
Three partners from academia and five from industry.
Our consortium connects quantum information, quantum computing, quantum algorithms, quantum chemistry, computational chemistry, ultra-low field magnetic resonance imaging, computational physics, hardware engineering and quantum-AI IT interface architecture engineering into one project. Find out more about these topics on our Learn page.
News
Publications, events and updates from the project.
- 27 Nov 2026 Kick-off meeting. Novartis Pharma, Fabrikstrasse 2, 4056 Basel
- 01 Oct 2026 Official project start.
Funded by the SCNAT Swiss Quantum Initiative under grant agreement TRL_F_YG